News Coverage 04.23.21 Share on Twitter Share on Facebook Share on LinkedIn Tumor-infiltrating lymphocytes show ‘provocative’ response rates in advanced melanoma Related Announcement PICI 2024: Collaborative Breakthroughs in Cancer Immunotherapy Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research Announcement PICI Network Investigators Propel Immunotherapy Progress at SITC 2024
Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research